Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-11-27

Clinical Trial Update: Study to Examine Effect of Recombinant Luteinizing Hormone (r-Lh) and Recombinant Human Chorionic Gonadotropin (r-hCG) for Ovarian Stimulation in Assisted Reproduction Techniques (ART) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating recombinant LH and recombinant hCG for ovarian stimulation in assisted reproduction techniques; the study is completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Recombinant Human Chorionic Gonadotropin (r-hCG) (Chorionic Gonadotropin, recombinant)
  • Recombinant Luteinizing Hormone (r-LH) (Luteinizing Hormone, recombinant)

Snippet

Sponsor: Regionshospitalet Viborg, Skive | Conditions: Controlled Ovarian Stimulation, Infertility | Phase 4 | Status: COMPLETED | Results posted: 2013-11-27